,ticker,comment,username,score,permalink,neg,neu,pos,compound
0,ASX," The investment opportunity is both in the long run, but Orthocell (OCC) trades at a modest $100 million on the ASX.  

I'd suggest investors look at Fate Therapeutics stock price since it partnered with J&J April 2020 for an indication of the potential.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8pdigw/,0.0,0.956,0.044,0.2263
1,DEX," This place is a gem for crypto fansâ€¦ Maybe you can also say anything about Flat Earth?! I came across their DEX, and I am considering using this!",Dear-Lingonberry5545,0,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8ol7kb/,0.0,1.0,0.0,0.0
2,TGA," Exactly - tendon injuries and chronic tendon concerns such as tendonitis and tendonosis. Think rotator cuff, tennis elbow and the like. Absolutely groundbreaking tech and not the only platform treatment out of Orthocell. Already approved for other technologies with the FDA and TGA such as their CelGro platform.",FatBradPitt101,5,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mpwu9/,0.0,0.895,0.105,0.6486
3,OCC," Ha, ha.  I ask myself the same question daily.  Look at Fate therapeutics that had a partnership with Johnson and Johnson last year in cancer stem cell treatments.  OCC also has approval with EMA, FDA and TGA in a separate collagen scaffold treatment.  Australia is a small and myopic market at times obsessed with banks and mining.",Historical_Job_8609,2,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mwesv/,0.098,0.774,0.127,0.2023
4,TGA," Ha, ha.  I ask myself the same question daily.  Look at Fate therapeutics that had a partnership with Johnson and Johnson last year in cancer stem cell treatments.  OCC also has approval with EMA, FDA and TGA in a separate collagen scaffold treatment.  Australia is a small and myopic market at times obsessed with banks and mining.",Historical_Job_8609,2,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mwesv/,0.098,0.774,0.127,0.2023
5,ASX," No.  Orthocell.com.au

OCC on the ASX.

They are only just starting in the US with a collagen scaffold for bone regeneration mainly in dental applications at the moment following recent FDA approval.  They are also on the verge of the same for nerve repair.

The US market for its stem-cell treatment (ATI) is probably not going to begin until Johnson and Johnson decide on partnership on back of results to be announced this quarter.",Historical_Job_8609,2,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8nk1vp/,0.029,0.931,0.041,0.2263
6,OCC," No.  Orthocell.com.au

OCC on the ASX.

They are only just starting in the US with a collagen scaffold for bone regeneration mainly in dental applications at the moment following recent FDA approval.  They are also on the verge of the same for nerve repair.

The US market for its stem-cell treatment (ATI) is probably not going to begin until Johnson and Johnson decide on partnership on back of results to be announced this quarter.",Historical_Job_8609,2,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8nk1vp/,0.029,0.931,0.041,0.2263
7,IIII," Yep.  I am hoping JNJ and they partner and do a large phase IIII study.  That said they've performed over 1,000 treatments to date with stem cells.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8pak3i/,0.0,0.821,0.179,0.6124
8,JNJ," Yep.  I am hoping JNJ and they partner and do a large phase IIII study.  That said they've performed over 1,000 treatments to date with stem cells.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8pak3i/,0.0,0.821,0.179,0.6124
9,MCA," Large government funded stem cell trial using  MCA precursor Mesenchymal stem cells in knee OA. By Cynata (CYP/ in Australia, but personally I prefer chondrocyte stem cells by Orthocell (OCC).  Stem cells aren't a miracle cure.   Tenocyte stem cells may help in shoulder if tendon issues. Mesenchymal stem cells helped me avoid surgery in a torn shoulder labrum, bit it depends on the injury.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8p6dmp/,0.18,0.771,0.049,-0.8611
10,IT," What's the main concern? ""idiots"" is a nice assumption but unless it's IT mid-managers it may be more to it. 

- What are the risk factors?

- How would JNJ's collab/sponsorship convert to an all-out production and how much would they benefit from it?

- I don't have OCC.AX on my broker so unless there's a path for JNJ to have a sizeable bump there's not much to it

- How long would a market for this kind of product take to take-off?

JNJ's a good company overall to invest in i suppose, if there's a dip to take advantage.",postblitz,0,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mw2hp/,0.027,0.84,0.134,0.89
11,JNJ," What's the main concern? ""idiots"" is a nice assumption but unless it's IT mid-managers it may be more to it. 

- What are the risk factors?

- How would JNJ's collab/sponsorship convert to an all-out production and how much would they benefit from it?

- I don't have OCC.AX on my broker so unless there's a path for JNJ to have a sizeable bump there's not much to it

- How long would a market for this kind of product take to take-off?

JNJ's a good company overall to invest in i suppose, if there's a dip to take advantage.",postblitz,0,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mw2hp/,0.027,0.84,0.134,0.89
12,OCC," What's the main concern? ""idiots"" is a nice assumption but unless it's IT mid-managers it may be more to it. 

- What are the risk factors?

- How would JNJ's collab/sponsorship convert to an all-out production and how much would they benefit from it?

- I don't have OCC.AX on my broker so unless there's a path for JNJ to have a sizeable bump there's not much to it

- How long would a market for this kind of product take to take-off?

JNJ's a good company overall to invest in i suppose, if there's a dip to take advantage.",postblitz,0,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8mw2hp/,0.027,0.84,0.134,0.89
13,FATE," Of course. Not least of which FDA cronyism/incompetence as Mesoblast find out when 9 out of 10 ODAC appointees by the FDA voted in favour of its steroid refractory GVHD treatment but the FDA declined.  The FDA has actually approved some stem cell treatments to date, contrary to popular opinion and recently relevant to this company approved an autologous stem cell trial in MS with Mesenchymal stem cells.

They have done over 1,000 stem cell clinical treatments in across Australia with no deployment, safety or legal issues to date. They have over 100 patents including various  tenocyte and chondrocyte stem cell applications.

The only problem with this phase III stock that already has FDA approval in a collagen device, is that it cant't gain any recognition.  I am on FATE in the US and that quadrupled on JNJ partnership in a year to some $6 billon.  This stocks is a laughable $100 Million mkt cap.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8n03sd/,0.037,0.799,0.164,0.969
14,III," Of course. Not least of which FDA cronyism/incompetence as Mesoblast find out when 9 out of 10 ODAC appointees by the FDA voted in favour of its steroid refractory GVHD treatment but the FDA declined.  The FDA has actually approved some stem cell treatments to date, contrary to popular opinion and recently relevant to this company approved an autologous stem cell trial in MS with Mesenchymal stem cells.

They have done over 1,000 stem cell clinical treatments in across Australia with no deployment, safety or legal issues to date. They have over 100 patents including various  tenocyte and chondrocyte stem cell applications.

The only problem with this phase III stock that already has FDA approval in a collagen device, is that it cant't gain any recognition.  I am on FATE in the US and that quadrupled on JNJ partnership in a year to some $6 billon.  This stocks is a laughable $100 Million mkt cap.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8n03sd/,0.037,0.799,0.164,0.969
15,JNJ," Of course. Not least of which FDA cronyism/incompetence as Mesoblast find out when 9 out of 10 ODAC appointees by the FDA voted in favour of its steroid refractory GVHD treatment but the FDA declined.  The FDA has actually approved some stem cell treatments to date, contrary to popular opinion and recently relevant to this company approved an autologous stem cell trial in MS with Mesenchymal stem cells.

They have done over 1,000 stem cell clinical treatments in across Australia with no deployment, safety or legal issues to date. They have over 100 patents including various  tenocyte and chondrocyte stem cell applications.

The only problem with this phase III stock that already has FDA approval in a collagen device, is that it cant't gain any recognition.  I am on FATE in the US and that quadrupled on JNJ partnership in a year to some $6 billon.  This stocks is a laughable $100 Million mkt cap.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8n03sd/,0.037,0.799,0.164,0.969
16,MS," Of course. Not least of which FDA cronyism/incompetence as Mesoblast find out when 9 out of 10 ODAC appointees by the FDA voted in favour of its steroid refractory GVHD treatment but the FDA declined.  The FDA has actually approved some stem cell treatments to date, contrary to popular opinion and recently relevant to this company approved an autologous stem cell trial in MS with Mesenchymal stem cells.

They have done over 1,000 stem cell clinical treatments in across Australia with no deployment, safety or legal issues to date. They have over 100 patents including various  tenocyte and chondrocyte stem cell applications.

The only problem with this phase III stock that already has FDA approval in a collagen device, is that it cant't gain any recognition.  I am on FATE in the US and that quadrupled on JNJ partnership in a year to some $6 billon.  This stocks is a laughable $100 Million mkt cap.",Historical_Job_8609,1,/r/investing/comments/p2rdap/johnson_and_johnson_about_to_announce_4_year/h8n03sd/,0.037,0.799,0.164,0.969
17,IMO," > The fine print states the the loan is not secured; borrowers post no collateral. So, if I participate, **I understand that the coins I loan out may never be returned.** This brings several questions to mind and I'd love to hear some thoughts:

>1) Is there any way to assess the level of risk here?

I mean, the bolded answers this question for me instantly. I hold plenty of crypto personally. But its already high risk. I refuse to compound that risk with stuff like this. This is just reckless IMO. People chasing even higher 'interest' on crypto always end up like the Bitconnect scam from years back. IMO this is a silly thing to do. You already hold an extremely risky asset. Gambling a second tier of it like this is just absurd in my eyes.",TripTryad,21,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8n805t/,0.154,0.728,0.119,-0.6758
18,ETH," Shouldnt you be asking in the crypto subreddit? People around here is somehow skeptic on crypto currencies or anything related to crypto.

I think you can get better returns investing in other things.

Snp500 is normally 10-12% yearly. If you dont want that, BTC and ETH can net you more than 7.4% by just buying and holding BTC or ETH in a year.

All investment have risk. Companies minting stable coins normally do it so that you give them real USD for backed coins so that you can use it to trade crypto currencies. And then they use your money to invest that money and make money this way.  Sort of like a bank but a lot less regulated. I dont know if there is any big stable coin companies that has gone down because they cannot back their minted coins.",zethras,24,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8mg2qi/,0.029,0.906,0.065,0.6173
19,APR," Voyager digital is offering 9-10% APR on USDC.  No promises the rate will stay that high, and it is NOT FDIC insured, but IMO, definitely a woethwhile place to put some cash.",asanano,2,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8nuzwr/,0.046,0.801,0.153,0.5789
20,IMO," Voyager digital is offering 9-10% APR on USDC.  No promises the rate will stay that high, and it is NOT FDIC insured, but IMO, definitely a woethwhile place to put some cash.",asanano,2,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8nuzwr/,0.046,0.801,0.153,0.5789
21,HUT," I know HUT 8 (canadian bitcoin miner) does have an account with genesis generating interest on some bitcoin, I forget how much but it is a substantial amount.",woosniffles,1,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8nq8st/,0.054,0.788,0.158,0.4118
22,DD," >""easy""

>""easy returns""

>rate way above normal rate

Not saying you can't or shouldn't do this.

 Just saying nothing is ""easy"". Do your DD and homework or you could be in for a rude awakening.",zxc123zxc123,1,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8obduw/,0.083,0.917,0.0,-0.4588
23,PAX," tldr: Ledn then Gemini if you're depositing under $5m. Avoid platforms with their own token.

***

You get 2% less with Gemini (9.5% vs 7.4%) but I split between them for platform and stablecoin diversification (USDC and GUSD). Gemini also has a Bitlicence in addition to money transmitter license which adds extra compliance credibility.

Stick to fully backed coins like USDC, PAX, GUSD.

Nothing is risk free but Genesis, the underlying lender, has had zero defaults since 2013ish through multiple brutal drawdowns that would have Lehman'ed many tradfi firms and debt instruments.

They are of course making more yield with the lent money but unless you can do the derivatives and carry trades yourself this is a moot point. 

For extra security I diversify between a grid of different platforms and stablecoins. Three platforms and three coins gives you 9 risk ""buckets"" in case of some technical or compliance fault. Defi lending adds another dimension (and you can self insure with defi insurance like Nexus Mutual).

In this negative yield environment I see no reason not to have at least half of your cash/bond allocation in stablecoins. These are even competitive with stocks with little drawdown risk.",notapersonaltrainer,43,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8nu36r/,0.119,0.788,0.093,-0.8681
24,ETH," I am posting here because these crypto-loaning programs are seemingly analogous to bonds. This investment return is not a gamble on the change in asset values, but a gamble on someone's ability to repay a loan. I am more curious about the repayment and loan machinations; not so much the crypto itself.

 

>Snp500 is normally 10-12% yearly. If you dont want that, BTC and ETH can net you more than 7.4% by just buying and holding BTC or ETH in a year.

The goal of this investment is to create a steady, predictable growth and diversify against equity price risk. Most investors do not want 100% of their portfolio in stocks. And please pardon me if I laugh at your confident estimates of BTC or ETH growth over time. I'm sure they ""can"" net much, much more in a year, just as I'm sure they ""can"" lose half their value in a month. I find them too new, and the environment too unstable, to be assigning confident growth averages.",15pH,16,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8mn1ev/,0.06,0.684,0.256,0.9906
25,PAX," > Stick to fully backed coins like USDC, PAX, GUSD.

""Fully backed"" doesn't mean what it used to.

https://www.bloomberg.com/news/articles/2021-08-11/coinbase-drops-promise-of-token-s-cash-backing-that-wasn-t-true

> For months, a visitor to the website of Coinbase Global Inc., the largest U.S. cryptocurrency exchange, would see that the company offered a stablecoin called USD Coin with a simple premise: For every dollar offered to investors, there was $1 â€œin a bank accountâ€ to back it.

> That promise was important for the stablecoin, which unlike Bitcoin has a set price and can be redeemed by users for regular currency. It helped USD Coin grow to be the worldâ€™s second-largest stablecoin, with $28 billion in assets. 

> But when Circle Internet Financial Inc., Coinbaseâ€™s partner in offering the coin, disclosed USD Coinâ€™s assets for the first time last month, it turns out the promise wasnâ€™t true.

> According to a disclosure in July, the assets actually include commercial paper, corporate bonds and other assets that could experience losses and are less liquid if customers ever tried to redeem the stablecoin en masse.",murray_paul,24,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8o4e0p/,0.02,0.848,0.132,0.9114
26,USA," SEC ginslers definition of a stable coin and what it constitutes. But tbh I gave my opinion and information but im just going to let this go not fighting the down vote bots. Im not shilling crypto 

but someone saying cyber security insurance doesnâ€™t exist as being true was too much to not atleast try.

Any CEX operating in America still has federal requirements to be licensed and operates in the USA. Consumer protections donâ€™t disappear thats federally protected.",AnonBoboAnon,-14,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8mgpf6/,0.027,0.804,0.169,0.9112
27,YOU," Here's Maker DAOs: https://docs.defisafety.com/finished-reviews/draft-0.7-makerdao#audits

Here's liquity's: https://docs.defisafety.com/finished-reviews/liquefy#audits

Guys, these things aren't hard to look up. *Everything* is open source and available. YOU could do the audit.",silent_johnn,0,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8nd3rw/,0.0,0.951,0.049,0.0762
28,USA," > Any CEX operating in America still has federal requirements to be licensed and operates in the USA. Consumer protections donâ€™t disappear thats federally protected.

Exactly what I've been thinking I feel okay about cefi based in the U.S",sixniks,0,/r/investing/comments/p2t45w/easy_74_returns_by_loaning_out_stablecoins/h8mm5gb/,0.047,0.835,0.118,0.4404
29,QCOM, QCOM is very undervalued. I see it going up 20% in the next year based on their revenue and growth forecasts...,newaxetrader,10,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8ofp15/,0.0,0.88,0.12,0.3818
30,OTEX, Thanks!! Long OTEX,BeyondExcellent,2,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8oyrxr/,0.0,0.365,0.635,0.5399
31,DEX," This place is a miracle for crypto fansâ€¦ Maybe ya can also say something about Flat Earth?! I came across their DEX, and I am considering using this!",ResidentSympathy7714,0,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8pb8wz/,0.0,0.846,0.154,0.658
32,QCOM," QRVO and QCOM have been two of my long plays since they went on sale in late January.  I couldn't fully understand why they struggled so much throughout the year since, but I kept buying because they still feel undervalued to me.

So excited to see some actual analysis that supports my hunches!",CaptMercaptan,3,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8p42pt/,0.03,0.821,0.15,0.7834
33,QRVO," QRVO and QCOM have been two of my long plays since they went on sale in late January.  I couldn't fully understand why they struggled so much throughout the year since, but I kept buying because they still feel undervalued to me.

So excited to see some actual analysis that supports my hunches!",CaptMercaptan,3,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8p42pt/,0.03,0.821,0.15,0.7834
34,HUGE," Yeah, right. I already realized (too late) there is a HUGE mistrust towards stock analysts. I understand this and I'll try to shift focus towards more objective criteria.",investing-scientist2,1,/r/investing/comments/p2v8y4/thirteen_stocks_possibly_worth_attention_a/h8p67ox/,0.0,0.815,0.185,0.6408
35,ES," I'm a stock market newbie, so just curious as I'm looking through /ES futures this year and I noticed a possible pattern...

Ignoring the first 2 months because memestock's

3/17 - 3/19 - Red days

4/18 - 4/20 - Red days

5/17 - Red day

6/16 - 6/18 - Red days

7/14 - 7/19 - Red days

SPY has the same thing around the 14-18th of every month for as far back as I looked.

Am I just seeing a pattern because I want to see one? Or is this a thing? Why would the middle of each month have red days?",throtic,6,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8o3lun/,0.031,0.919,0.05,0.1824
36,TSM," TSM seems like it's at a fair price right now, anything I'm missing? I want to start a small position",PM_ME_HOT__TAKES,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8nck1b/,0.103,0.61,0.286,0.4404
37,DKS," Any opinions on $ASO? All the stores in my region are always busy. Great P/E ratio. Seems to beat or be comparable to DKS in many metrics, but doesnâ€™t get the love.",Xavis_Daddy,2,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8p6550/,0.0,0.782,0.218,0.8537
38,AMZN, Will AMZN bounce back?,FB_emeenem,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8oaode/,0.0,1.0,0.0,0.0
39,PBTS, Do y'all think that PBTS to invest in the digital yuan?,Aeon_Flux_Capacitor,1,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8nux1g/,0.0,1.0,0.0,0.0
40,BB," Hi all - I'm a noob invester and don't really know what I'm doing. I managed to save up Â£10,000 over the last couple of years, and currently over Â£6,000 of it sits in shares. 25% Tesla, 25% Nio, 10% BB (I know stupid), and the rest is made up of smaller percentages.

Overall I believe in all these companies (except maybe BB) and I am willing to hold long-term. I am not interested in short-term trading. However, I am beginning to wonder whether I have been kind of stupid, and that maybe I should sell all of this for the small loss of Â£100 that I'm currently at, and invest this money into myself. 

My life is at a bit of a turning point, and I am making my living as a freelancer. I make decent money as a copywriter, but the whole reason I started that was so that I could earn more money as a freelance musician. If I sold my shares, I would relieve my financial pressure for the next year or so and I could focus on working every day on my music freelance career. 

Basically TLDR, I don't know wtf I am doing with investment, and I think I have gone too deep. Do you think that I should sell my shares for a loss and start from scratch, perhaps going back in in the future? Or is long term investment a pretty safe thing to do? As mentioned I'm making decent money so it's not like that Â£6,000 is emergency money, but I'm just thinking in terms of being smart.

Sorry for the ramble, I hop someone can offer some advise!",ThrwAway93234,1,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8pag52/,0.071,0.799,0.129,0.9616
41,TDA," Each broker has pluses and minuses. It sort of depends on what you want most in your trading.

TDA is typically rated highly by frequent traders as far as all around qualities.",WeenisWrinkle,1,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8p86sd/,0.0,0.96,0.04,0.0772
42,BNTX," "" I'm considering paying the $1,299 to join their Biotech Breakthroughs subscription/news service (discounted from $1,999 today only)""

why

""Are you considering paying for the service and why or why not?""

Hard pass.

I don't have any interest in paying for subscription services and especially something that costs almost $1,999 (but is ""ONE DAY ONLY"" 1299.)

The other issue with MF is that it often feels like a number of their picks are released during the trading day. I had a few instances last year of something I owned mooning out of nowhere during the trading day and I found out MF had recommended it. So people are paying for recommendations, waiting for the drop and then trying to see if they can be first in a feeding frenzy? Why not release reports in the evening so people can read, research a little and consider an investment the next day after putting some thought into it?

EDIT: And just after I wrote this, some discussion/rumor that NET (which I do own) is up out of nowhere because of MF recommendation. 

I also just like doing my own research.

With biotech, I owned several names last year (and then BNTX/MRNA this year, which I've sold the last of recently) but it's such a difficult, volatile industry. I was fascinated learning about what I invested in last year but I realized that I don't have a healthcare background and was supported by massive inflows into things like ARKG. As the year went on, I really thought I'd take the W on most of the names because the moves seemed unsustainable and I just really wanted fewer names that I had to monitor/think about. I have no specific biotech holdings at this point. Would definitely not be opposed to revisiting specific biotechs, but would probably be much less than what I devoted to it last year and would really probably be no more than one or two specific names.

 I'm not against owning biotechs, but I do think that life science names that serve the biotech and broader scientific community are just such easier long-term plays that don't require consistent monitoring. Things like TMO, DHR as just long-term get/forget plays on this theme.",dvdmovie1,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8ntb82/,0.04,0.861,0.099,0.9691
43,DHR," "" I'm considering paying the $1,299 to join their Biotech Breakthroughs subscription/news service (discounted from $1,999 today only)""

why

""Are you considering paying for the service and why or why not?""

Hard pass.

I don't have any interest in paying for subscription services and especially something that costs almost $1,999 (but is ""ONE DAY ONLY"" 1299.)

The other issue with MF is that it often feels like a number of their picks are released during the trading day. I had a few instances last year of something I owned mooning out of nowhere during the trading day and I found out MF had recommended it. So people are paying for recommendations, waiting for the drop and then trying to see if they can be first in a feeding frenzy? Why not release reports in the evening so people can read, research a little and consider an investment the next day after putting some thought into it?

EDIT: And just after I wrote this, some discussion/rumor that NET (which I do own) is up out of nowhere because of MF recommendation. 

I also just like doing my own research.

With biotech, I owned several names last year (and then BNTX/MRNA this year, which I've sold the last of recently) but it's such a difficult, volatile industry. I was fascinated learning about what I invested in last year but I realized that I don't have a healthcare background and was supported by massive inflows into things like ARKG. As the year went on, I really thought I'd take the W on most of the names because the moves seemed unsustainable and I just really wanted fewer names that I had to monitor/think about. I have no specific biotech holdings at this point. Would definitely not be opposed to revisiting specific biotechs, but would probably be much less than what I devoted to it last year and would really probably be no more than one or two specific names.

 I'm not against owning biotechs, but I do think that life science names that serve the biotech and broader scientific community are just such easier long-term plays that don't require consistent monitoring. Things like TMO, DHR as just long-term get/forget plays on this theme.",dvdmovie1,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8ntb82/,0.04,0.861,0.099,0.9691
44,MF," "" I'm considering paying the $1,299 to join their Biotech Breakthroughs subscription/news service (discounted from $1,999 today only)""

why

""Are you considering paying for the service and why or why not?""

Hard pass.

I don't have any interest in paying for subscription services and especially something that costs almost $1,999 (but is ""ONE DAY ONLY"" 1299.)

The other issue with MF is that it often feels like a number of their picks are released during the trading day. I had a few instances last year of something I owned mooning out of nowhere during the trading day and I found out MF had recommended it. So people are paying for recommendations, waiting for the drop and then trying to see if they can be first in a feeding frenzy? Why not release reports in the evening so people can read, research a little and consider an investment the next day after putting some thought into it?

EDIT: And just after I wrote this, some discussion/rumor that NET (which I do own) is up out of nowhere because of MF recommendation. 

I also just like doing my own research.

With biotech, I owned several names last year (and then BNTX/MRNA this year, which I've sold the last of recently) but it's such a difficult, volatile industry. I was fascinated learning about what I invested in last year but I realized that I don't have a healthcare background and was supported by massive inflows into things like ARKG. As the year went on, I really thought I'd take the W on most of the names because the moves seemed unsustainable and I just really wanted fewer names that I had to monitor/think about. I have no specific biotech holdings at this point. Would definitely not be opposed to revisiting specific biotechs, but would probably be much less than what I devoted to it last year and would really probably be no more than one or two specific names.

 I'm not against owning biotechs, but I do think that life science names that serve the biotech and broader scientific community are just such easier long-term plays that don't require consistent monitoring. Things like TMO, DHR as just long-term get/forget plays on this theme.",dvdmovie1,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8ntb82/,0.04,0.861,0.099,0.9691
45,NET," "" I'm considering paying the $1,299 to join their Biotech Breakthroughs subscription/news service (discounted from $1,999 today only)""

why

""Are you considering paying for the service and why or why not?""

Hard pass.

I don't have any interest in paying for subscription services and especially something that costs almost $1,999 (but is ""ONE DAY ONLY"" 1299.)

The other issue with MF is that it often feels like a number of their picks are released during the trading day. I had a few instances last year of something I owned mooning out of nowhere during the trading day and I found out MF had recommended it. So people are paying for recommendations, waiting for the drop and then trying to see if they can be first in a feeding frenzy? Why not release reports in the evening so people can read, research a little and consider an investment the next day after putting some thought into it?

EDIT: And just after I wrote this, some discussion/rumor that NET (which I do own) is up out of nowhere because of MF recommendation. 

I also just like doing my own research.

With biotech, I owned several names last year (and then BNTX/MRNA this year, which I've sold the last of recently) but it's such a difficult, volatile industry. I was fascinated learning about what I invested in last year but I realized that I don't have a healthcare background and was supported by massive inflows into things like ARKG. As the year went on, I really thought I'd take the W on most of the names because the moves seemed unsustainable and I just really wanted fewer names that I had to monitor/think about. I have no specific biotech holdings at this point. Would definitely not be opposed to revisiting specific biotechs, but would probably be much less than what I devoted to it last year and would really probably be no more than one or two specific names.

 I'm not against owning biotechs, but I do think that life science names that serve the biotech and broader scientific community are just such easier long-term plays that don't require consistent monitoring. Things like TMO, DHR as just long-term get/forget plays on this theme.",dvdmovie1,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8ntb82/,0.04,0.861,0.099,0.9691
46,TMO," "" I'm considering paying the $1,299 to join their Biotech Breakthroughs subscription/news service (discounted from $1,999 today only)""

why

""Are you considering paying for the service and why or why not?""

Hard pass.

I don't have any interest in paying for subscription services and especially something that costs almost $1,999 (but is ""ONE DAY ONLY"" 1299.)

The other issue with MF is that it often feels like a number of their picks are released during the trading day. I had a few instances last year of something I owned mooning out of nowhere during the trading day and I found out MF had recommended it. So people are paying for recommendations, waiting for the drop and then trying to see if they can be first in a feeding frenzy? Why not release reports in the evening so people can read, research a little and consider an investment the next day after putting some thought into it?

EDIT: And just after I wrote this, some discussion/rumor that NET (which I do own) is up out of nowhere because of MF recommendation. 

I also just like doing my own research.

With biotech, I owned several names last year (and then BNTX/MRNA this year, which I've sold the last of recently) but it's such a difficult, volatile industry. I was fascinated learning about what I invested in last year but I realized that I don't have a healthcare background and was supported by massive inflows into things like ARKG. As the year went on, I really thought I'd take the W on most of the names because the moves seemed unsustainable and I just really wanted fewer names that I had to monitor/think about. I have no specific biotech holdings at this point. Would definitely not be opposed to revisiting specific biotechs, but would probably be much less than what I devoted to it last year and would really probably be no more than one or two specific names.

 I'm not against owning biotechs, but I do think that life science names that serve the biotech and broader scientific community are just such easier long-term plays that don't require consistent monitoring. Things like TMO, DHR as just long-term get/forget plays on this theme.",dvdmovie1,3,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8ntb82/,0.04,0.861,0.099,0.9691
47,CME," Futures are a derivative market for various commodities like crude oil, copper, lean hogs, etc, and financial assets like the S&P 500 index and treasury yields. They trade almost 24 hours a day on exchanges CME and ICE. When the regular stock market is closed, people often refer to the futures market as an active and liquid indication of where the S&P 500 would be if the stock market were open, which is why you might have gotten the impression that they only trade at night.",kiwimancy,1,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8o6lf8/,0.039,0.821,0.14,0.7506
48,ICE," Futures are a derivative market for various commodities like crude oil, copper, lean hogs, etc, and financial assets like the S&P 500 index and treasury yields. They trade almost 24 hours a day on exchanges CME and ICE. When the regular stock market is closed, people often refer to the futures market as an active and liquid indication of where the S&P 500 would be if the stock market were open, which is why you might have gotten the impression that they only trade at night.",kiwimancy,1,/r/investing/comments/p2w1wn/daily_general_discussion_and_spitballin_thread/h8o6lf8/,0.039,0.821,0.14,0.7506
49,RDFN," They are up nearly 20% after market based on these results. RDFN, Z or ZG, and Open all have a bright future. Although I think Z and RDFN are better positioned, Open has some potential.",pandatears420,3,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8lgz98/,0.0,0.833,0.167,0.7003
50,ZG," They are up nearly 20% after market based on these results. RDFN, Z or ZG, and Open all have a bright future. Although I think Z and RDFN are better positioned, Open has some potential.",pandatears420,3,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8lgz98/,0.0,0.833,0.167,0.7003
51,OPEN," I'll just give context to some of the notes above along with my take: 

* Company still losing a lot of cash. As expected of a grow-at-all-costs tech company. All the growth techs actively push back their earnings/profit as much as possible. Even the FAAAMs still try to do this as megacaps.

* Share price went up despite the huge dollar losses because this company is valued on growth rather than profits atm. Important part is business growth, market expansion, increased homes bought/sold, increased inventory, and contracts.

* Another thing is to not get too freaked out by the debt & operating loss OR get too hyped about the big numbers for sales and pre-adjusted profit. The reason why is OPEN operates in the personal home and real estate space. These numbers are inflated due to the price of the good they sell. 5x leverage on $800K debt would mean you're from r/WSB if you're buying stocks but if you're buying homes then you're just Californian. These high home prices means OPEN will post big numbers. 

* That's why EBITDA is the better value to use here to value the company. Michael Burry himself prefers EV/EBITDA to P/E anyways because it's a better metric. P/E, sales, profit/loss, and other basic metrics might not be best to valuate OPEN or other home realtors who also do iBuying like Z.

My personal take is that thing are going as planned. Real estate market is hot. Z, OPEN, RDFN, and other real estate companies are disruptors and should have good future outlook. Having used opendoor myself, I think OPEN is disruptive. They undercut other agents, brokerages, and brokers while offering customers directly to agents looking for them. 

OPEN, Z, and other iBuyers are one of the reasons home buying is so hard for some millennials. They offer a quick & easy way to for home buyers to buy homes digitally, they undercut the brokerage fees, and will help their customers front all cash offers by buying the home first all cash. This leads to less tech savvy millennials complaining about all cash offers on TV. iBuyers also buy up the homes themselves. Sometimes they just buy it from their customers, other times they build inventory for their other customers, and other times they flip them. This also adds on to the woes of millennials feeling like big corps are pushing them out of the real estate market. Real problem is if you believe OPEN is better than Z or the potential ibuyers. I have a position in OPEN, but I would have a position in Z too if I had a good entry point.",zxc123zxc123,1,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8o9l23/,0.062,0.805,0.133,0.9831
52,OR," I'll just give context to some of the notes above along with my take: 

* Company still losing a lot of cash. As expected of a grow-at-all-costs tech company. All the growth techs actively push back their earnings/profit as much as possible. Even the FAAAMs still try to do this as megacaps.

* Share price went up despite the huge dollar losses because this company is valued on growth rather than profits atm. Important part is business growth, market expansion, increased homes bought/sold, increased inventory, and contracts.

* Another thing is to not get too freaked out by the debt & operating loss OR get too hyped about the big numbers for sales and pre-adjusted profit. The reason why is OPEN operates in the personal home and real estate space. These numbers are inflated due to the price of the good they sell. 5x leverage on $800K debt would mean you're from r/WSB if you're buying stocks but if you're buying homes then you're just Californian. These high home prices means OPEN will post big numbers. 

* That's why EBITDA is the better value to use here to value the company. Michael Burry himself prefers EV/EBITDA to P/E anyways because it's a better metric. P/E, sales, profit/loss, and other basic metrics might not be best to valuate OPEN or other home realtors who also do iBuying like Z.

My personal take is that thing are going as planned. Real estate market is hot. Z, OPEN, RDFN, and other real estate companies are disruptors and should have good future outlook. Having used opendoor myself, I think OPEN is disruptive. They undercut other agents, brokerages, and brokers while offering customers directly to agents looking for them. 

OPEN, Z, and other iBuyers are one of the reasons home buying is so hard for some millennials. They offer a quick & easy way to for home buyers to buy homes digitally, they undercut the brokerage fees, and will help their customers front all cash offers by buying the home first all cash. This leads to less tech savvy millennials complaining about all cash offers on TV. iBuyers also buy up the homes themselves. Sometimes they just buy it from their customers, other times they build inventory for their other customers, and other times they flip them. This also adds on to the woes of millennials feeling like big corps are pushing them out of the real estate market. Real problem is if you believe OPEN is better than Z or the potential ibuyers. I have a position in OPEN, but I would have a position in Z too if I had a good entry point.",zxc123zxc123,1,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8o9l23/,0.062,0.805,0.133,0.9831
53,RDFN," I'll just give context to some of the notes above along with my take: 

* Company still losing a lot of cash. As expected of a grow-at-all-costs tech company. All the growth techs actively push back their earnings/profit as much as possible. Even the FAAAMs still try to do this as megacaps.

* Share price went up despite the huge dollar losses because this company is valued on growth rather than profits atm. Important part is business growth, market expansion, increased homes bought/sold, increased inventory, and contracts.

* Another thing is to not get too freaked out by the debt & operating loss OR get too hyped about the big numbers for sales and pre-adjusted profit. The reason why is OPEN operates in the personal home and real estate space. These numbers are inflated due to the price of the good they sell. 5x leverage on $800K debt would mean you're from r/WSB if you're buying stocks but if you're buying homes then you're just Californian. These high home prices means OPEN will post big numbers. 

* That's why EBITDA is the better value to use here to value the company. Michael Burry himself prefers EV/EBITDA to P/E anyways because it's a better metric. P/E, sales, profit/loss, and other basic metrics might not be best to valuate OPEN or other home realtors who also do iBuying like Z.

My personal take is that thing are going as planned. Real estate market is hot. Z, OPEN, RDFN, and other real estate companies are disruptors and should have good future outlook. Having used opendoor myself, I think OPEN is disruptive. They undercut other agents, brokerages, and brokers while offering customers directly to agents looking for them. 

OPEN, Z, and other iBuyers are one of the reasons home buying is so hard for some millennials. They offer a quick & easy way to for home buyers to buy homes digitally, they undercut the brokerage fees, and will help their customers front all cash offers by buying the home first all cash. This leads to less tech savvy millennials complaining about all cash offers on TV. iBuyers also buy up the homes themselves. Sometimes they just buy it from their customers, other times they build inventory for their other customers, and other times they flip them. This also adds on to the woes of millennials feeling like big corps are pushing them out of the real estate market. Real problem is if you believe OPEN is better than Z or the potential ibuyers. I have a position in OPEN, but I would have a position in Z too if I had a good entry point.",zxc123zxc123,1,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8o9l23/,0.062,0.805,0.133,0.9831
54,TV," I'll just give context to some of the notes above along with my take: 

* Company still losing a lot of cash. As expected of a grow-at-all-costs tech company. All the growth techs actively push back their earnings/profit as much as possible. Even the FAAAMs still try to do this as megacaps.

* Share price went up despite the huge dollar losses because this company is valued on growth rather than profits atm. Important part is business growth, market expansion, increased homes bought/sold, increased inventory, and contracts.

* Another thing is to not get too freaked out by the debt & operating loss OR get too hyped about the big numbers for sales and pre-adjusted profit. The reason why is OPEN operates in the personal home and real estate space. These numbers are inflated due to the price of the good they sell. 5x leverage on $800K debt would mean you're from r/WSB if you're buying stocks but if you're buying homes then you're just Californian. These high home prices means OPEN will post big numbers. 

* That's why EBITDA is the better value to use here to value the company. Michael Burry himself prefers EV/EBITDA to P/E anyways because it's a better metric. P/E, sales, profit/loss, and other basic metrics might not be best to valuate OPEN or other home realtors who also do iBuying like Z.

My personal take is that thing are going as planned. Real estate market is hot. Z, OPEN, RDFN, and other real estate companies are disruptors and should have good future outlook. Having used opendoor myself, I think OPEN is disruptive. They undercut other agents, brokerages, and brokers while offering customers directly to agents looking for them. 

OPEN, Z, and other iBuyers are one of the reasons home buying is so hard for some millennials. They offer a quick & easy way to for home buyers to buy homes digitally, they undercut the brokerage fees, and will help their customers front all cash offers by buying the home first all cash. This leads to less tech savvy millennials complaining about all cash offers on TV. iBuyers also buy up the homes themselves. Sometimes they just buy it from their customers, other times they build inventory for their other customers, and other times they flip them. This also adds on to the woes of millennials feeling like big corps are pushing them out of the real estate market. Real problem is if you believe OPEN is better than Z or the potential ibuyers. I have a position in OPEN, but I would have a position in Z too if I had a good entry point.",zxc123zxc123,1,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8o9l23/,0.062,0.805,0.133,0.9831
55,ATH, I donâ€™t disagree broadly itâ€™s just an annoying week for me so Iâ€™m being a salty pouty lil bitch for a while. ATH forever. Meh. Itâ€™s just me.,blind_ekorre,6,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8lmqi1/,0.331,0.669,0.0,-0.8555
56,RKT," im really hoping for a buyout/partial stake from RKT or BRK or something. that would be so sweet. i mean BRK already got realty services, sitting on 140B in cashola...",ktn699,2,/r/investing/comments/p2nsdj/opendoor_openannounces_second_quarter_2021/h8lvfvd/,0.0,0.789,0.211,0.7881
57,MSCI," Low effort investing / ETF and 4 stocks -> advice on long term autopilot investment

Hi altogether,

I hope this post is here in the right place.

I realized that I developed an quite unwelcome behavior of checking stocks daily and everything what goes with it like getting nervous if they fall etc.

Initially I got into investing with the big core MSCI World ETF for long term investing.
Somehow it lead to buying small portions of stocks and trying to beat the market an so on.

I want to put my portfolio back on autopilot for a few years at least 5-15. 

For that I want to have this proportions:
70% ETF <- like the core MSCI World 

10% ETF <- like the core MSCI emerging markets

4 stocks * 5% <- this would be companyâ€™s I genuinely believe have a solid product

I have the following questions:

1. Are the proportions reasonable.
2. Should I just go for the biggest ETF or should I take a look at for example vanguard and the VGWL.
3. Instead of emerging markets should I consider a specialized ETF like green energy or some ESG ETF
4. I consider to put about 10 of the money allocated for investment on the side for eventualities like a small or medium bear market to be able in addition to cost averaging be able to get a better deal. Is this reasonable or schools I just put everything on autopilot?

Thank you in advance for your help!",attobit,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8n5wc8/,0.029,0.849,0.122,0.961
58,TFSA," Hi Investing ðŸ‘‹ 

Iâ€™m 32 in Canada. I work in an office, 60k/year. 

I currently have ~little~ savings that I have started to invest in a TFSA through WealthSimple. I want to focus on retirement security. 

I am receiving a lump sum (30k) that was willed to me and I donâ€™t want to screw it up. What is the best tool for investing? I have heard about QuestTrade in a Podcast, and I know people who invest through their bank (Iâ€™m with TD) but Iâ€™ve heard the fees are excessive. 

Iâ€™d like to invest in ETFs, but what are good resources for researching good options? I try reading Yahoo Finance but Iâ€™m unfamiliar with what makes a good/poor investment choice. 

Thank you so much for reading!",Alternative-Ear-1985,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8nojm9/,0.01,0.82,0.171,0.9598
59,EDIT," Hey everyone, I just received an interesting job offer where part of my salary will be paid as Basis Points(BPS) ownership of the company (Which is a startup and currently not worth very much).

I currently have a well paid and safe job, this job offer matches my current salary and adds 20 BPS ownership of the company.

Changing jobs will be taking a risk so those 20 BPS have to make a difference for me, there's also other secondary benefits for changing not relevant here that I'm taking into the equation.

EDIT:

The company just sent me a mock of the agreement that I will be signing, what I will be offered is called nonstatutory stock options (NSO).

This are some values taken from the agreement:Date of Grant: 1 September 2021Exercise Price per share: $0.0001Total Number of Shares: \_\_To be completed\_\_Total Exercise Price: \_\_To be completed\_\_Expiration Date: 30 Aug 2031Vesting Commencement Date 1 Sep 2021

**I have figured out most of those terms by now, what I'm missing is how those 20 BPS link to the total number of shares (To be completed)**

EDIT 2:Removed questions I made before having this agreement mock that are no longer relevant.",M4nch1,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8o814b/,0.065,0.789,0.146,0.9364
60,SONO," I recently opened a TD Ameritrade account after 3ish years with Stash as I got tired of the over-simplicity of Stash and their lack of education and buy/sell tools.  I've spent quite a bit of time in TDA's education section and am so far happy I made the switch.  However, I think I've made an error in my approach to buying and selling.  I learned how to do Conditionals and made a ton of trades as One Triggers Another (OTA).  I learned about Trailing Stops and realized maybe I should have done those instead of a stop market order with each Buy order.  I set up stop market orders as I was tired of watching my Stash investments dip to a point it was going to be difficult if not impossible to recover.  Because the conditionals are already partially executed (the Buy part), I cannot cancel the stop market order to replace with a Trailing Stop.  I'm thinking I should stop making all my orders conditional and do individual buy and sell orders with whatever method I think is best on the sell side (Stop Market or Trailing Stop).  I'm kicking myself as I have SONO and it's been doing really well, but I have it on a Stop market instead of a Trailing Stop so I could lose any gains I make.  Does anyone else use conditional orders in this manner?  Or am I making things harder on myself?",cost_guesstimator54,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p1cvb/,0.12,0.832,0.048,-0.9026
61,TD," I recently opened a TD Ameritrade account after 3ish years with Stash as I got tired of the over-simplicity of Stash and their lack of education and buy/sell tools.  I've spent quite a bit of time in TDA's education section and am so far happy I made the switch.  However, I think I've made an error in my approach to buying and selling.  I learned how to do Conditionals and made a ton of trades as One Triggers Another (OTA).  I learned about Trailing Stops and realized maybe I should have done those instead of a stop market order with each Buy order.  I set up stop market orders as I was tired of watching my Stash investments dip to a point it was going to be difficult if not impossible to recover.  Because the conditionals are already partially executed (the Buy part), I cannot cancel the stop market order to replace with a Trailing Stop.  I'm thinking I should stop making all my orders conditional and do individual buy and sell orders with whatever method I think is best on the sell side (Stop Market or Trailing Stop).  I'm kicking myself as I have SONO and it's been doing really well, but I have it on a Stop market instead of a Trailing Stop so I could lose any gains I make.  Does anyone else use conditional orders in this manner?  Or am I making things harder on myself?",cost_guesstimator54,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p1cvb/,0.12,0.832,0.048,-0.9026
62,MKD," Anyone own any Molecular Data MKD stock? I invested last year and have taken considerable losses. Any advice would be appreciated, or opinions about the future of the company and whether things may improve or did I choose a complete stinker?",Ilikeagoodsandwich,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p9h0e/,0.114,0.743,0.143,0.3313
63,ABG," I'm looking at a small market cap stock (Play Magnus) that I believe is well positioned in the market, although it doesn't yet break even. It's 12 days until earnings and for the past months it has been moving horizontally while four C-levels and some other insiders have been buying for a total of â‚¬800k. ABG Sunndal Collier values them at twice the current price. Is this a good time to buy?",Wiz_Kalita,0,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8mvnw7/,0.0,0.888,0.112,0.8006
64,IRS," If it is that big a gain, you may owe the IRS estimated tax now.  It's something you are supposed to pay in quarterly if you aren't withholding enough; and if you don't you will owe penalties and interest in April on top of the income tax.  It might be wise to consult an accountant now and not find out you've made a big mistake later.",LiqCourage,2,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8ohtsi/,0.052,0.793,0.155,0.8176
65,IRS," You should never gamble with borrowed money. This money belongs to Uncle Sam. You should never gamble with money you can not afford to lose. This tax money is money you cannot afford to lose. At best you end up with a short term loan paying the IRS points on money you lost. At worst, they take everything else you own & you end up selling yourself in prison for candy bars. The fact that you asked here already says you are affected psychologically. You have already lost in your mind. This is a NO win, NO win scenario. Listen to ""u/iopeneverydoor"" below & make that estimated tax payment.",John_III_XVI,2,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8ok00g/,0.151,0.722,0.127,-0.2846
66,TD," Every brokerage will have positives and negatives. The nice thing about Robinhood is that it's easy to use, access. and has instant deposits.  


Sometimes is pays to be investing with a brokerage that is a partner with your bank. For example, if you have money in an account at Bank of America and use one of their credit cards, then it's wise to consider investing using Merril Edge because your balance there will count towards your overall balance for reward programs.  


If you want to invest using little money, some brokerages let you buy ""fractional shares"", meaning instead of being forced to buy 1 share of Stock A for $500, you could buy 0.5 shares of that stock for $250, and so on. I think TD Ameritrade and a few brokerages allow this, but make sure to do your research.",FridayTendies,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p58fd/,0.014,0.841,0.145,0.9186
67,IMO," IMO, start looking at companies and thinking about what you like and don't about the company, what is exciting and what might be questionable/potentially problematic? What is the moat? What do customer and/or employee reviews say? Eventually you'll be able to know more and more what you're looking for and be able to go through companies and decide whether something is worth further exploration or you reach a point where it's not of interest and it's on to the next one.

 Start looking around noticing themes and themes don't have to be shiny and sleek to do well - I invested in pet healthcare 5 years ago and that did extremely well. I invested in generators (GNRC) last Fall. 

I don't think that CNBC is a good thing at all. There's so many great companies that never get a mention - it's a lot of the same names over and over. Bloomberg is somewhat better.

I think there's some great podcasts and interviews (Good Investing Talks on Youtube is a good one - https://www.youtube.com/channel/UC5Z-C01O2VlpeD1rMs_HS2Q, Invest like the Best w/Patrick O'Shaughnessy is great) and listen to investors talk about what they found compelling about certain companies they invested in and their approach.

I think what you have to try to do is to find great companies early on before they have some news announcement that everyone tries to chase. Does the company solve a problem? Is it superbly managed? Does it offer a new, better way to do a common task? Is there a potentially huge market? Is it a durable growth story with a long runway or is it a fad?",dvdmovie1,2,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p67sj/,0.028,0.77,0.203,0.9928
68,TV," I'm not a sophisticated trader by any means, but Bloomberg seems to be a pretty reliable source of day-to-day information. If you have an Etrade account, you have access to Bloomberg TV which is nice to keep running in the background. Lot of technical jargon on their broadcast, but listen long enough and you'll begin to pick up the gist of it.

As far as day trading is concerned, I wouldn't touch that unless you really know what you're doing. Proceed at your own peril.",HubcapMotors,1,/r/investing/comments/p2w1dc/daily_advice_thread_all_basic_help_or_advice/h8p2w7g/,0.06,0.852,0.087,0.5405
69,APPH," I like the vertical farming space but when I looked at APPH and Aerofarms, I thought they were overvalued.   I also expected some significant seasonal variation especially for tomatoes since most are grown in this country during the summer months.   I was waiting for it collapse (I do not short because you cannot control downside risk), but will re-look at them now.  The r/AppHarvest has some good information.

On Aerofarms, I like the materials and location strategy they are pursuing but the financial disclosures have me worried and will also wait on them.",stickman07738,2,/r/investing/comments/p2pest/appharvests_disappointing_results/h8mxrtg/,0.071,0.798,0.131,0.6199
70,APPH," Everyone would buy in at $3 on a stock that had a $35 high during SPAC-mania before it came to an end in March 2021. It won't see that low, assuming no black swan events.

I was aware of tomato produce limits this year (droughts everywhere) and definitely should have bought puts, but I didn't think APPH would do this bad. They basically lowered all of their near-term guidance while maintaining their 2025 outlook - which is complete baloney anyway because all of these garbage SPACs with their 2025 revenue promises/outlooks are overpromising without any delivery short-term. While it's likely not a scam business, I'm expecting APPH to have some dead cat bounce off the tailwinds of a choppy-yet-bullish market towards OPEX next week, then we'll see where things go. August historically doesn't end well for markets and we're sitting at tip-top valuations blah blah you know the deal, asset bubbles are at all time highs and stocks like APPH contribute to that a great deal.

Stock's probably worth where it's sitting now around 8-9 dollars. Will need to see Q3 guidance and how they spend some of that cash flow going into the tougher season for produce but I doubt they'll make any significant rebounds on the business side for the next quarter. But as I said, dead cat bounce possibility - play it short term and set a strict stop loss.",Inori92,-1,/r/investing/comments/p2pest/appharvests_disappointing_results/h8lopx7/,0.134,0.756,0.11,-0.805
71,AI," No, They're disrupting the tomato growing business with revolutionary tomato growing capabilities enabled by the blockchain or AI or something... please us the buzzwords or it just sounds like a very expensive greenhouse",Aminita_Muscaria,6,/r/investing/comments/p2pest/appharvests_disappointing_results/h8moz9y/,0.059,0.722,0.219,0.6124
72,IP," Does anyone know if the tomatoes taste good? The company has no IP, just scale. Scaled produce is typically bland.

If they could make ultra high quality produce close to markets, or maybe exotic produce normally found in a rainforest for Michelin star quality restaurants (and make it economically viable), then it would be more interesting.

It seems like a future value stock that should trade at 8x earnings that disguised itself as a tech company to raise capital 5 years too early.",BYoung001,6,/r/investing/comments/p2pest/appharvests_disappointing_results/h8ly5up/,0.049,0.829,0.123,0.7574
73,APPH," No I haven't seen many 90% discount on stocks in the last 4-5 years, even NKLA which is the poster-boy for SPAC disaster is trading, well actually NKLA is about at 80-90% down from ATH lol. But NKLA has no revenue at all and is all empty promises until fulfillment, or signs alluding to that. 

Anyways, I'm more addressing that your target valuation of ~$3-4 might be correct but there are going to be buyers at levels above who are probably not going to let it go down to your level. Again, you might be questioning that and all I can say is only time will tell, NKLA is a very rare occurrence. So no, on my end, I don't see very many 90% discounts / fire-sales or stocks plummeting to that degree to meet ""fair value"". 

Also your last paragraph confuses me a bit because I agree with you and I wouldn't pay it myself, and I also think APPH is not doing anything all that revolutionary - Netherlands have already done it. I just think those valuations / fundamentals don't really matter in the current markets, it's more about flow and with a dip like what APPH has, there will be buyers at some point.",Inori92,-2,/r/investing/comments/p2pest/appharvests_disappointing_results/h8lqzb8/,0.084,0.834,0.083,0.2042
74,ATH," No I haven't seen many 90% discount on stocks in the last 4-5 years, even NKLA which is the poster-boy for SPAC disaster is trading, well actually NKLA is about at 80-90% down from ATH lol. But NKLA has no revenue at all and is all empty promises until fulfillment, or signs alluding to that. 

Anyways, I'm more addressing that your target valuation of ~$3-4 might be correct but there are going to be buyers at levels above who are probably not going to let it go down to your level. Again, you might be questioning that and all I can say is only time will tell, NKLA is a very rare occurrence. So no, on my end, I don't see very many 90% discounts / fire-sales or stocks plummeting to that degree to meet ""fair value"". 

Also your last paragraph confuses me a bit because I agree with you and I wouldn't pay it myself, and I also think APPH is not doing anything all that revolutionary - Netherlands have already done it. I just think those valuations / fundamentals don't really matter in the current markets, it's more about flow and with a dip like what APPH has, there will be buyers at some point.",Inori92,-2,/r/investing/comments/p2pest/appharvests_disappointing_results/h8lqzb8/,0.084,0.834,0.083,0.2042
75,NKLA," No I haven't seen many 90% discount on stocks in the last 4-5 years, even NKLA which is the poster-boy for SPAC disaster is trading, well actually NKLA is about at 80-90% down from ATH lol. But NKLA has no revenue at all and is all empty promises until fulfillment, or signs alluding to that. 

Anyways, I'm more addressing that your target valuation of ~$3-4 might be correct but there are going to be buyers at levels above who are probably not going to let it go down to your level. Again, you might be questioning that and all I can say is only time will tell, NKLA is a very rare occurrence. So no, on my end, I don't see very many 90% discounts / fire-sales or stocks plummeting to that degree to meet ""fair value"". 

Also your last paragraph confuses me a bit because I agree with you and I wouldn't pay it myself, and I also think APPH is not doing anything all that revolutionary - Netherlands have already done it. I just think those valuations / fundamentals don't really matter in the current markets, it's more about flow and with a dip like what APPH has, there will be buyers at some point.",Inori92,-2,/r/investing/comments/p2pest/appharvests_disappointing_results/h8lqzb8/,0.084,0.834,0.083,0.2042
